Clin2
NCT06760533Possibly a fitNot yet recruiting

Psilocybin therapy for irritable bowel syndrome

IBS - Irritable Bowel Syndrome

Treatments studied

Part of Digestive system clinical trials.

This trial tests whether psilocybin-assisted psychotherapy can help people with severe irritable bowel syndrome (IBS) who have not gotten better with standard treatments. Psilocybin is a psychedelic substance that may help reset brain-gut connections to reduce symptoms.

Summary written for real people, not researchers, by Clin2.

Phase
Early Phase 1
Enrollment
10 people
Ages
18 years to 75 years
Study type
Interventional

Who can take part

  • You have severe IBS (as defined by a symptom score or needing emergency care for belly pain in the past year).
  • IBS symptoms persist despite taking IBS medicines.
  • You have a support person who can accompany you home after the psilocybin dose.
  • If you can become pregnant, you agree to use effective birth control during the study.
  • You are willing to share your outside medical records to confirm eligibility.
  • You are not taking certain medications (like antidepressants or other serotonin-related drugs) and have no serious heart, liver, kidney, or mental health conditions that could make the treatment unsafe.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07172139Not yet recruiting
Brain stimulation and gut treatments for diarrhea-predominant IBS

This trial tests whether combining brain stimulation (called transcranial magnetic stimulation) with either a medication or a probiotic can help reduce diarrhea and belly pain in people with IBS. If you join, you'll receive one of these combinations to see if it improves your symptoms.

NCT07168434Recruiting· Phase 3
Yeast supplement for irritable bowel syndrome (IBS)

This trial tests if a yeast supplement called Saccharomyces boulardii can help people with irritable bowel syndrome (IBS), except for those with constipation as their main symptom. Participants take the supplement and see if their symptoms improve.

Braga
NCT07238790Not yet recruiting· Early Phase 1
Bacteria treatment for diarrhea-type irritable bowel syndrome

This trial tests a new treatment made from a mix of bacteria that live in the gut. It aims to improve symptoms of irritable bowel syndrome with diarrhea (IBS-D) in people who have certain gut bacteria imbalances.

Redwood City, California
NCT06433180Not yet recruiting· Phase 3
Fecal transplant for severe irritable bowel syndrome

This trial tests whether a fecal microbiota transplantation (FMT), which transfers healthy bacteria from a donor into your gut, can reduce severe irritable bowel syndrome (IBS) symptoms. FMT is being studied as a possible new treatment for people with IBS that hasn't improved with other treatments.

Bobigny
NCT07872514Enrolling by invitation
Personalized probiotics for irritable bowel syndrome

This study tests whether a probiotic treatment designed specifically for you can help ease your irritable bowel syndrome (IBS) symptoms. If you make it into the study, you'll get a treatment plan tailored to your gut and your symptoms.

Hamilton, Ontario
NCT06940596Recruiting
Comparing diets and therapies for irritable bowel syndrome

This study compares different dietary and behavioral treatments to find out which works best for different people with irritable bowel syndrome (IBS). You'll be asked to follow a specific treatment program to see how it affects your symptoms.

Melbourne, Victoria

Hear when a new IBS - Irritable Bowel Syndrome trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.